Skip to content
SVM$8.34-0.30(-3.47%)SILVERCORP REPORTS ADJUSTED NET INCOME OF $18.4 MILLION, $0.08 PER SHARE, AND CASH FLOW FROM OPERATING ACTIVITIES OF $62.7 MILLION FOR Q2 FISCAL 20275:06:04 PM ETNET$279.99+13.41(+5.03%)Cloudflare Q3 revenue beats estimates on AI platform demand5:05:25 PM ETTMO$680.00-26.16(-3.70%)Thermo Fisher Scientific Announces Quarterly Dividend5:00:04 PM ETWPM$131.25-0.25(-0.19%)Wheaton Precious Metals Announces Third Quarter 2026 Results and Record Year-to-Date Production, Sales Volume, Revenue, Earnings and Cash Flow5:00:00 PM ETTSX:SAP$41.620.00(0.00%)Saputo Reports Financial Results for the Second Quarter of Fiscal 2027 Ended September 30, 20265:00:00 PM ETNET$279.99+13.41(+5.03%)Cloudflare Stock Surges on Lifted Full-Year Outlook, Third-Quarter Revenue Growth5:00:00 PM ETMNST$45.09-3.66(-7.51%)Monster Beverage Q3 sales beat estimates as marketing investments boost results4:56:44 PM ETEOG$144.89-2.17(-1.48%)UPDATE 2-US shale producer EOG Resources beats profit estimates on higher crude prices4:55:18 PM ETANTUPDATE 1-A&O Shearman's $1.1 billion AI plan builds on law firms' tech investments4:51:58 PM ETDNA$9.76-1.89(-16.21%)Ginkgo Bioworks Q3 revenue falls compared to last year4:51:51 PM ETABX$8.83-0.22(-2.43%)Abacus Global Management Q3 revenue, adjusted EBITDA beat estimates4:51:39 PM ETPRTA$7.89-0.50(-5.96%)Prothena Q3 net loss narrows on lower costs4:51:15 PM ETLRCX$193.00-28.43(-12.84%)BUZZ-Chip firm Lam Research rises after announcing $25 bln stock buyback4:50:28 PM ETEOG$144.89-2.17(-1.48%)EOG Resources Q3 revenue ease past estimates amid strong price realizations4:49:39 PM ETNVDA$181.88-18.25(-9.12%)Stock Market Today, Nov. 5: Nvidia Slides on AI Chip Selloff as Election Uncertainty Weighs4:49:38 PM ETCVS$81.01+1.05(+1.31%)AM Best Places Credit Ratings of CVS Health Corporation’s Aetna Inc. Subsidiaries Under Review with Developing Implications4:49:03 PM ETPTGX$135.26-8.11(-5.66%)Protagonist Therapeutics Q3 revenue surges on Takeda payments4:48:48 PM ETVERX$17.47+1.55(+9.74%)Prediction: Vertex Pharmaceuticals Will Be 1 of the Best Biotech Stocks to Own Over the Next 5 Years4:47:00 PM ETETOLF$1.22-0.02(-1.61%)Enterprise Prices $1.5 Billion Aggregate Principal Amount of Senior Notes4:47:00 PM ETEPD$36.62-0.09(-0.25%)Enterprise Prices $1.5 Billion Aggregate Principal Amount of Senior Notes4:47:00 PM ETSPG$225.88-2.63(-1.15%)Simon Property Q3 Real Estate FFO per share rises; 2026 outlook raised4:46:33 PM ETEOG$144.89-2.17(-1.48%)UPDATE 1-US shale producer EOG Resources beats quarterly profit estimates on higher crude prices4:45:57 PM ETWFC$84.52-2.91(-3.33%)Wells Fargo & Company (WFC) Presents at BancAnalysts Association of Boston Conference 2026 Transcript4:45:03 PM ETMNST$45.09-3.66(-7.51%)Monster Beverage Profit Rises as International Sales Jump4:44:00 PM ET

SOLV · NYSE

Solventum Corporation

$81.05 -8.30 (-9.29%)

Company overview

Solventum Corporation, a healthcare company, engages in developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment provides solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. The Dental Solutions segment provides a comprehensive suite of dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents.

Sector
Healthcare
Industry
Medical - Care Facilities
Exchange
NYSE
Market cap
$13.8B
Employees
22,000
Headquarters
Maplewood, MN
CEO
Bryan C. Hanson
Listed
April 1, 2024
P/E
9.87
Dividend yield
0.00%

Company financials

Revenue
$8.3B
Gross profit
$4.4B
Operating income
$2.1B
EBITDA
$2.8B
Net income
$1.4B
EPS
$8.21
Total assets
$14.1B
Total debt
$5.1B
Gross margin
53.67%
Net margin
17.33%
Earnings yield
10.13%

Revenue segmentation

By product (FY 2025)
By region (FY 2025)

Showing FY 2025

Price chart

65.1472.6880.2187.7495.28
SOLV 1D NYSE O87.49H90.61L87.48C89.35+4.59 (+5.42%)Vol2.17M

News

15-min delaySigned-out view is delayed 15 minutes. Log in on Pro for the live news desk.

Source
Date
Type
View
Ticker Type Headline Source Published
SOLVSolventum Corporation Stock news Gear Up for Solventum (SOLV) Q3 Earnings: Wall Street Estimates for Key Metrics Zacks Investment Research
SOLVSolventum Corporation Press release SOLV Energy Expands High-Voltage Infrastructure Capabilities with Acquisition of ASB Energy Services GlobeNewswire
SOLVSolventum Corporation Stock news SOLV's Q3 Earnings: Can Growth Momentum Offset ERP-Related Headwinds? Zacks Investment Research
SOLVSolventum Corporation Press release Membrane Chromatography Market worth $0.63 billion by 2031 - Exclusive Report by MarketsandMarkets™ PR Newswire
SOLVSolventum Corporation Stock news Solventum (SOLV) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release Zacks Investment Research
SOLVSolventum Corporation Stock news Here's Why Solventum (SOLV) is a Strong Value Stock Zacks Investment Research
SOLVSolventum Corporation Press release Infection Control Market to Grow from US$ 58.5 Bn in 2026 to US$ 80.2 Bn by 2031 at 6.5% CAGR as Hospitals Automate Reprocessing: Wissen Research PR Newswire
SOLVSolventum Corporation Stock news SOLV Wins FDA Clearance to Combine Restrata Matrix With V.A.C.Therapy Zacks Investment Research
SOLVSolventum Corporation Press release SOLV Energy to Report Third Quarter 2026 Financial Results on November 12, 2026 GlobeNewswire
SOLVSolventum Corporation Press release Solventum Announces FDA 510(k) Clearance for Combined Use of Restrata™ Matrix and Solventum™ V.A.C.® Therapy* Solventum (NYSE: SOLV), a leader in advanced wound healing, announced today that the U.S. PR Newswire
SOLVSolventum Corporation Press release Solventum to Report Third Quarter Fiscal 2026 Earnings on November 5, 2026 Solventum (NYSE: SOLV) will release its third quarter fiscal 2026 financial results on Thursday, November 5, 2026, after the U.S. financial markets... PR Newswire
SOLVSolventum Corporation Stock news Can Solventum (SOLV) Keep the Earnings Surprise Streak Alive? Zacks Investment Research
SOLVSolventum Corporation Stock news Why Solventum (SOLV) is a Top Value Stock for the Long-Term Zacks Investment Research
SOLVSolventum Corporation Stock news Head to Head Contrast: Solventum (NYSE:SOLV) & Tandem Diabetes Care (NASDAQ:TNDM) Defense World
SOLVSolventum Corporation Stock news Solventum: Divestiture Unlocking Upside In A Spinoff Revaluation Play Seeking Alpha
SOLVSolventum Corporation Stock news Here's Why You Should Hold Solventum Stock in Your Portfolio for Now Zacks Investment Research
SOLVSolventum Corporation Stock news Here's Why Solventum (SOLV) is a Strong Value Stock Zacks Investment Research
SOLVSolventum Corporation Stock news Why Solventum (SOLV) is a Top Stock for the Long-Term Zacks Investment Research
SOLVSolventum Corporation Stock news Solventum Corporation (SOLV) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript Seeking Alpha
SOLVSolventum Corporation Stock news Solventum (SOLV) Up 11.4% Since Last Earnings Report: Can It Continue? Zacks Investment Research
FAQ

Questions about Solventum Corporation

What does Solventum Corporation do?
Solventum Corporation, a healthcare company, engages in developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment provides solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. The Dental Solutions segment provides a comprehensive suite of dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents.
What is SOLV's market cap?
Solventum Corporation (SOLV) is a listed stock with a live quote. The latest market cap on this page is $13.8B.
Where is Solventum Corporation headquartered?
Solventum Corporation is headquartered in Maplewood, MN.
How do I get SOLV news from the API?
Call GET /v1/news?tickers=SOLV. Add type=news, type=press_release, or type=legal to take one feed. Pro keys search articles since 2020 in real time. Free keys are delayed 15 minutes and return the last year. Signed-out visitors and Free accounts see that same year on this page. Pro sees articles since 2020.
How far back does SOLV news go?
Signed-out visitors and Free accounts see the last year of stock news, press releases, and legal notices for SOLV, 15 minutes behind, and each headline links to the publisher. Pro, including the 7-day trial, sees articles since 2020 as headlines are ingested. A Free API key returns the last year. Pro keys search articles since 2020.
Is the SOLV price on this page from the API?
The price and daily change update during the US session for every visitor. That quote is context on this page. It is not part of the news API. The chart is one candle per session from the start of 2020. 1W, 1M, and 1Y group those sessions.
Can I use the Pro plan commercially?
No. The Pro plan cannot be used for commercial work. A product you sell, work you do for a client, or redistribution of the feed needs a custom plan and a license. Email [email protected].

Real-time stock news for $15 a month.

Start a 7-day Pro trial. A card is required. REST, WebSocket, and MCP are included, with 250 REST requests a day, 1 WebSocket connection, 5 requests per second, and 2,500 WebSocket messages a day. You won't be charged during the trial. Unless you cancel, the card is billed for Pro when it ends.